325 related articles for article (PubMed ID: 35570314)
1. Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index.
Teranishi Y; Okano A; Miyawaki S; Ohara K; Ishigami D; Hongo H; Dofuku S; Takami H; Mitsui J; Ikemura M; Komura D; Katoh H; Ushiku T; Ishikawa S; Shin M; Nakatomi H; Saito N
Acta Neuropathol Commun; 2022 May; 10(1):76. PubMed ID: 35570314
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genomic differences in supratentorial versus infratentorial NF2 mutant meningiomas.
Tabor JK; O'Brien J; Vasandani S; Vetsa S; Lei H; Jalal MI; Marianayagam NJ; Jin L; Millares Chavez M; Haynes J; Dincer A; Yalcin K; Aguilera SM; Omay SB; Mishra-Gorur K; McGuone D; Morales-Valero SF; Fulbright RK; Gunel M; Erson-Omay EZ; Moliterno J
J Neurosurg; 2023 Dec; 139(6):1648-1656. PubMed ID: 37243548
[TBL] [Abstract][Full Text] [Related]
3. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
4. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
[TBL] [Abstract][Full Text] [Related]
5. Genomic analysis of spinal meningiomas: correlation with histopathological grade.
Driver J; Santagata S; Bi WL; Chi JH
J Neurosurg Spine; 2023 Dec; 39(6):729-733. PubMed ID: 37728381
[TBL] [Abstract][Full Text] [Related]
6. NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas.
Vasan V; Dullea JT; Devarajan A; Ali M; Rutland JW; Gill CM; Kinoshita Y; McBride RB; Gliedman P; Bederson J; Donovan M; Sebra R; Umphlett M; Shrivastava RK
J Neurooncol; 2023 Jan; 161(2):309-316. PubMed ID: 36436149
[TBL] [Abstract][Full Text] [Related]
7. Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes.
Ren L; Hua L; Deng J; Cheng H; Wang D; Chen J; Xie Q; Wakimoto H; Gong Y
Neurosurgery; 2023 Apr; 92(4):745-755. PubMed ID: 36512828
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M
J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196
[TBL] [Abstract][Full Text] [Related]
9. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas.
Schieffer KM; Agarwal V; LaHaye S; Miller KE; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly BJ; Crist E; Rusin J; Finlay JL; Osorio DS; Sribnick EA; Leonard JR; Feldman A; Orr BA; Serrano J; Vasudevaraja V; Snuderl M; White P; Magrini V; Wilson RK; Mardis ER; Boué DR; Cottrell CE
Am J Surg Pathol; 2021 Mar; 45(3):329-340. PubMed ID: 33074854
[TBL] [Abstract][Full Text] [Related]
10. Inherited genetic syndromes and meningiomas.
Look A; Lonser RR
Handb Clin Neurol; 2020; 169():121-129. PubMed ID: 32553283
[TBL] [Abstract][Full Text] [Related]
11. NF2 gene expression in sporadic meningiomas: relation to grades or histotypes real time-pCR study.
Buccoliero AM; Castiglione F; R Degl'Innocenti D; Gheri CF; Garbini F; Taddei A; Ammannati F; Mennonna P; Taddei GL
Neuropathology; 2007 Feb; 27(1):36-42. PubMed ID: 17319281
[TBL] [Abstract][Full Text] [Related]
12. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases.
Wang XQ; Jiang CC; Zhao L; Gong Y; Hu J; Chen H
J Neurosurg Pediatr; 2012 Nov; 10(5):423-33. PubMed ID: 22938082
[TBL] [Abstract][Full Text] [Related]
14. Clinical potential of meningioma genomic insights: a practical review for neurosurgeons.
Karsy M; Azab MA; Abou-Al-Shaar H; Guan J; Eli I; Jensen RL; Ormond DR
Neurosurg Focus; 2018 Jun; 44(6):E10. PubMed ID: 29852774
[TBL] [Abstract][Full Text] [Related]
15. Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas.
Tabernero M; Jara-Acevedo M; Nieto AB; Caballero AR; Otero A; Sousa P; Gonçalves J; Domingues PH; Orfao A
BMC Med Genet; 2013 Oct; 14():114. PubMed ID: 24171707
[TBL] [Abstract][Full Text] [Related]
16. Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.
Kalamarides M; Stemmer-Rachamimov AO; Takahashi M; Han ZY; Chareyre F; Niwa-Kawakita M; Black PM; Carroll RS; Giovannini M
Brain Pathol; 2008 Jan; 18(1):62-70. PubMed ID: 17924978
[TBL] [Abstract][Full Text] [Related]
17. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
[TBL] [Abstract][Full Text] [Related]
18. Associations of meningioma molecular subgroup and tumor recurrence.
Youngblood MW; Miyagishima DF; Jin L; Gupte T; Li C; Duran D; Montejo JD; Zhao A; Sheth A; Tyrtova E; Özduman K; Iacoangeli F; Peyre M; Boetto J; Pease M; Avşar T; Huttner A; Bilguvar K; Kilic T; Pamir MN; Amankulor N; Kalamarides M; Erson-Omay EZ; Günel M; Moliterno J
Neuro Oncol; 2021 May; 23(5):783-794. PubMed ID: 33068421
[TBL] [Abstract][Full Text] [Related]
19. Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
Abi Jaoude S; Peyre M; Degos V; Goutagny S; Parfait B; Kalamarides M
J Neurosurg; 2020 May; 134(5):1377-1385. PubMed ID: 32442973
[TBL] [Abstract][Full Text] [Related]
20.
Sakai Y; Miyawaki S; Teranishi Y; Okano A; Ohara K; Hongo H; Ishigami D; Shimada D; Mitsui J; Nakatomi H; Saito N
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
